Skip to main content

Table 1 Clinical characteristics of study subjects

From: Atrial natriuretic peptide and three-dimensional echocardiography after transcatheter closure of atrial septal defect

 

Patients with ASD

(n = 46)

Control subject

(n = 22)

p

Value

Age(years)

26.32 ± 13.28

24.81 ± 9.04

NS

Sex(M/F)

20/26

12/10

NS

ASD (TEE) (mm)

27.42 ± 5.92

  

ASD (balloon) (mm)

25.34 ± 7.80

  

PAP(mmHg)

36.48 ± 10.30

  

RVEDV(ml)

106.54 ± 25.97

69.78 ± 10.46

<0.05

RVESV(ml)

59.73 ± 17.59

33.84 ± 7.18

<0.05

RVEF(%)

44.10 ± 4.72

51.92 ± 5.35

<0.05

ANP(ng/L)

156.42 ± 75.10

82.85 ± 17.80

<0.05

  1. Data are presented mean value ± SD or number (%). ASD = atrial septal defect; TEE = transesophageal echocardiography; RVEDV = right ventricular end-diastolic volume; RVESV = right ventricular end-systolic volume; RVEF = right ventricular ejection fraction; ANP = atrial natriuretic peptide
Back to article page

Cardiovascular Ultrasound

ISSN: 1476-7120

Contact us